Mihir Shah

机构：Research Triangle Park Foundation, AstraZeneca (Poland), AstraZeneca (Spain), Stanford University · ORCID：0000-0003-0854-2384

发表论文 39 篇 · 总被引 2740 次 · h-index 16

代表论文

• Systems vaccinology of the BNT162b2 mRNA vaccine in humans (2021 · Nature · 被引 594)
• Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination (2022 · Cell · 被引 510)
• Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial (2021 · The Lancet · 被引 365)
• Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System (2021 · JAMA Network Open · 被引 138)
• Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives (2021 · Allergy · 被引 115)
• CRISPR-GPT for agentic automation of gene-editing experiments (2025 · Nature Biomedical Engineering · 被引 91)